Aurobindo Pharma Limited revenue 2020 to 2023

Published by Statista Data Department, Mar 14, 2025
The revenue of Aurobindo Pharma Limited with headquarters in India amounted to 287 billion Indian rupees in 2023. The reported fiscal year ends on March 31.

Compared to the earliest depicted value from 2020 this is a total increase by approximately 41 billion Indian rupees. The trend from 2020 to 2023 shows, however, that this increase did not happen continuously.

Revenue of Aurobindo Pharma Limited from 2020 to 2023 (in billion Indian rupees)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2025

Region

India

Survey time period

2020 to 2023

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Aurobindo Pharma Limited "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Aurobindo Pharma Limited

Productivity KPIs

1

Profitability KPIs

3

Balance Sheet KPIs

3

Cash Flow KPIs

1

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

TevaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.